Cargando…

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers

The efficient and accurate execution of clinical trials testing novel treatments for Alzheimer's disease (AD) is a critical component of the field's collective efforts to develop effective disease‐modifying treatments for AD. The lengthy and heterogeneous nature of clinical progression in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Welsh‐Bohmer, Kathleen A., Kerchner, Geoffrey A., Dhadda, Shobha, Garcia, Miguel, Miller, David S., Natanegara, Fanni, Raket, Lars Lau, Robieson, Weining, Siemers, Eric R., Carrillo, Maria C., Weber, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585126/ https://www.ncbi.nlm.nih.gov/pubmed/37867532 http://dx.doi.org/10.1002/trc2.12421

Ejemplares similares

Interim Editors Bring Breadth of Experience
por: Korach, Kenneth S.
Publicado: (2007)

Editorial Note: New Interim Editor-in-Chief
Publicado: (2007)

Genomic biomarkers in predictive medicine. An interim analysis
por: Simon, Richard
Publicado: (2011)

Understanding ADHD: Toward an Innovative Therapeutic Intervention
por: Camp, Allyson, et al.
Publicado: (2021)

Correlating WHO COVID-19 interim guideline 2020.5 and testing capacity, accuracy, and logistical challenges in Africa
por: Mosi, Lydia, et al.
Publicado: (2021)

REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results
por: Olshansky, Brian, et al.
Publicado: (2020)

Modified reference based imputation and tipping point analysis in the presence of missing data due to COVID-19
por: Jin, Man, et al.
Publicado: (2021)

Encouraging innovation
por: Hyman, Anthony A.
Publicado: (2014)

Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)

Opening the door to innovation
por: Schuurman, Janine, et al.
Publicado: (2014)

Disruptive innovation in psychiatry
por: Sarris, Jerome
Publicado: (2022)

Interim analyses of data as they accumulate in laboratory experimentation
por: Ludbrook, John
Publicado: (2003)

Statistical Disease Progression Modeling in Alzheimer Disease
por: Raket, Lars Lau
Publicado: (2020)

Accelerating health system innovation: principles and practices from the Duke Institute for Health Innovation
por: Sandhu, Sahil, et al.
Publicado: (2023)

Disruptive Innovation and Health Literacy
por: Geskey, Joseph M.
Publicado: (2018)

Leadership for Innovation in Healthcare: An Exploration
por: Weintraub, Philip, et al.
Publicado: (2018)

Digital health innovation in cardiology
por: Ladejobi, Adetola O., et al.
Publicado: (2020)

Making space for Aboriginal and Torres Strait Islander community health workers in health promotion
por: Conte, Kathleen P, et al.
Publicado: (2019)

Global Blindness: The Progress We Are Making and Still Need to Make
por: Taylor, Hugh R.
Publicado: (2019)

Differential privacy for public health data: An innovative tool to optimize information sharing while protecting data confidentiality
por: Dyda, Amalie, et al.
Publicado: (2021)

Refractive surgery today: is there innovation or stagnation?
por: Alio, Jorge
Publicado: (2014)

The insurability of innovative pharmaceutical cancer technologies
por: Greenberg, Shuli Brammli, et al.
Publicado: (2020)

Excipient Innovation Through Precompetitive Research
por: Yu, Yihua Bruce, et al.
Publicado: (2021)

Making machine learning matter to clinicians: model actionability in medical decision-making
por: Ehrmann, Daniel E., et al.
Publicado: (2023)

Stopping rules, interim analyses and data monitoring committees.
por: Ashby, D., et al.
Publicado: (1993)

Interim analyses and stopping rules in cancer clinical trials.
por: Whitehead, J.
Publicado: (1993)

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
por: Klein, Gregory, et al.
Publicado: (2019)

Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry
por: Poewe, Werner, et al.
Publicado: (2020)

Empowering grassroots innovation to accelerate biomedical research
por: Greshake Tzovaras, Bastian, et al.
Publicado: (2021)

Innovative approaches towards an economic fusion reactor
por: Guo, Houyang, et al.
Publicado: (2020)

Centralization and innovation: Competing priorities for health systems?
por: Scarffe, Andrew D., et al.
Publicado: (2022)

Break to Make a Connection
por: Saito, Takamune T., et al.
Publicado: (2011)

Making De-Extinction Mundane?
por: Friese, Carrie, et al.
Publicado: (2014)

The Emotions in Bioethical Decision-making
por: Glick, Shimon M.
Publicado: (2022)

Innovation in observation: a vision for early outbreak detection
por: Fefferman, NH, et al.
Publicado: (2010)

Key drivers of biomedical innovation in cancer drug discovery
por: Huber, Margit A, et al.
Publicado: (2015)

Experiments in interdisciplinarity: Responsible research and innovation and the public good
por: Delgado, Ana, et al.
Publicado: (2018)

Beyond “implementation”: digital health innovation and service design
por: Shaw, James, et al.
Publicado: (2018)

An innovative interactive presentation for oral clinico-pathological conference
por: Yu, Chuan-Hang
Publicado: (2022)

Gillian Hanson: UK innovator in intensive care medicine
por: Ferry, Georgina
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u2da611klsihuchmckiuaj4a2t